ALTHX — Thx Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Thx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.15 | -6.57 | -6.83 | -1.77 | -3 |
| Depreciation | |||||
| Non-Cash Items | 0.328 | -0.381 | -0.001 | -2.23 | -0.392 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.514 | 1.24 | 0.215 | 0.53 | 1.81 |
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.14 | -5.37 | -6.36 | -3.37 | -0.884 |
| Capital Expenditures | -0.151 | -0.074 | -0.044 | -0.033 | -0.257 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.397 | -0.018 | 0.11 | 0.089 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.151 | 0.324 | -0.061 | 0.077 | -0.168 |
| Financing Cash Flow Items | -0.066 | 1.19 | 0.743 | 0.068 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.61 | 1.63 | 2.22 | -0.646 | 7.85 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.31 | -3.42 | -4.2 | -3.94 | 6.8 |